Sepsis Bacterial
15
4
5
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
6.7%
1 terminated out of 15 trials
83.3%
-3.2% vs benchmark
7%
1 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (15)
Effect of Direct-from-blood Bacterial Testing on Antibiotic Administration and Clinical Outcomes
A Validation Study of the Lab Clasp Device: A Point of Care Sepsis Risk Monitor
Therapeutic Options for CRAB
Prospective Validation of GRADY: A Machine Learning Model for Early Sepsis and Bacteremia Detection in ICU Patients
Performance of the SeptiCyte LAB Test for Antibiotic Stewardship in Mesenteric Ischemia
Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial Sepsis
Molecular Culture for the Diagnosis of Pediatric Sepsis
A Case Report of a Patient With Intellectual Disability and Neurogenic Bladder Complicated With Sepsis
18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia
Analytical Validation of the abioSCOPE Device With the IVD CAPSULE PSP Test: Comparison of PSP Values Measured With Venous Whole Blood and Those Measured With Arterial Whole Blood.
Detecting Sepsis in Patients With Severe Subarachnoideal Hemorrhage
Function of Circulating Exosomes in Sepsis-induced Immunosuppression
Piloting Clinical Bacteriology in the Ebola Virus Disease Care Response
Mortality Due to Septic Shock Associated With Thrombocytopenia
Quantification of Bacterial DNA in Sepsis